ABOUT  |  NEWS  |  PRODUCTS   |  TECHNOLOGY  |  INVESTOR RELATIONS  |  CAREER  |  PATIENTS

PRODUCTS

More information about our products

  CELL-BASED
  GENE THERAPY

  CANCER THERAPY
  WITH dSLIM

CONTACT

Investor & Public Relations

  Mr. Joerg Petrass

Research & Development

  Dr. Matthias Schroff

Business Development

  Ms. Arlett Killat

NEWS

Aug. 29, 2011

MOLOGEN AG: First evaluation data on clinical trial with MGN1601 - results for renal cancer therapy considerably better than anticipated
 

 the press release

Aug. 12, 2011

MOLOGEN AG Interim Financial Report: Clinical cancer studies are progressing according to plan
 

 the press release